[ad_1] Novavax NVAX, +5.24% stands out as a stark reminder of the biotech sector’s faltering…
Respiratory Tract Diseases
-
-
STOCK MARKET
Pfizer to more than double price of its COVID antiviral once drug moves to commercial market
by userby user[ad_1] Pfizer Inc. will charge $1,390 for a five-day course of its Paxlovid COVID-19 antiviral…
-
STOCK MARKET
Amgen to continue to seek full approval of Lumakras cancer drug after FDA panel votes against it
by userby user[ad_1] Amgen Inc. said it would continue to work closely with the Food and Drug…
-
[ad_1] Moderna Inc. announced positive interim results from a Phase 1/2 trial of its combination…
-
STOCK MARKET
‘COVID isn’t done with us’: So why have so many people started rolling the dice?
by userby user[ad_1] Hersh Shefrin, a mild-mannered behavioral economist at Santa Clara University, still wears a mask…
-
[ad_1] An antiviral drug that was granted an emergency use authorization by the U.S. Food…
-
STOCK MARKET
Free COVID tests: How to get 4 more rapid at-home tests from the government
by userby user[ad_1] The Biden administration recently announced that starting Monday, U.S. households will again be able…
-
STOCK MARKET
Long-COVID patients have clear hormonal and immune differences, research shows, raising hope for treatments
by userby user[ad_1] In patients with long COVID, hormonal and immune function is clearly different than in…
-
STOCK MARKET
Merck and Eisai say two lung-cancer trials failed to meet their main goals
by userby user[ad_1] Merck and Japanese partner Eisai said Friday that two late-stage trials of a treatment…
-
[ad_1] Evidence is mounting that the much-anticipated and much-feared “baby bust” has morphed instead into…